As we move towards more personalized medicine, the importance of precision diagnostics is increasing. Yet, most molecular diagnostics testing remains complex, inefficient, and out of reach for many ...
MENLO PARK, Calif., Sept. 15, 2025 /PRNewswire/ -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced ...
The new offering provides precise fetal risk assessment for up to 14 prevalent and actionable recessive and X-linked conditions, in addition to aneuploidies, as early as nine weeks into pregnancy — ...
UNITY is the only commercially available non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a single maternal blood draw. “Surpassing ...
The study concludes that an effective single-gene NIPT workflow, like UNITY Fetal Risk Screen, can considerably improve outcomes and bolster equity in prenatal care MENLO PARK, Calif., Oct. 30, 2023 ...